Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma.

Dillon PM, Petroni GR, Horton BJ, Moskaluk CA, Fracasso PM, Douvas MG, Varhegyi N, Zaja-Milatovic S, Thomas CY.

Clin Cancer Res. 2017 Aug 1;23(15):4138-4145. doi: 10.1158/1078-0432.CCR-16-2942. Epub 2017 Apr 4.

2.

Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.

Rodrigues RS, Oliveira RA, Li Y, Zaja-Milatovic S, Costa LB, Braga Neto MB, Kolling GL, Lima AA, Guerrant RL, Warren CA.

J Infect Dis. 2013 May 15;207(10):1505-15. doi: 10.1093/infdis/jit041. Epub 2013 Jan 28.

3.

Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection.

Warren CA, Li Y, Calabrese GM, Freire RS, Zaja-Milatovic S, van Opstal E, Figler RA, Linden J, Guerrant RL.

Infect Immun. 2012 Dec;80(12):4463-73. doi: 10.1128/IAI.00782-12. Epub 2012 Oct 8.

4.

Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis.

Azevedo OG, Oliveira RA, Oliveira BC, Zaja-Milatovic S, Araújo CV, Wong DV, Costa TB, Lucena HB, Lima RC Jr, Ribeiro RA, Warren CA, Lima AÂ, Vitek MP, Guerrant RL, Oriá RB.

BMC Gastroenterol. 2012 Jul 13;12:35. doi: 10.1186/1471-230X-12-35.

5.

RAF265 inhibits the growth of advanced human melanoma tumors.

Su Y, Vilgelm AE, Kelley MC, Hawkins OE, Liu Y, Boyd KL, Kantrow S, Splittgerber RC, Short SP, Sobolik T, Zaja-Milatovic S, Dahlman KB, Amiri KI, Jiang A, Lu P, Shyr Y, Stuart DD, Levy S, Sosman JA, Richmond A.

Clin Cancer Res. 2012 Apr 15;18(8):2184-98. doi: 10.1158/1078-0432.CCR-11-1122. Epub 2012 Feb 20. Erratum in: Clin Cancer Res. 2012 Aug 15;18(16):4475.

6.

Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury.

Milatovic D, Gupta RC, Yu Y, Zaja-Milatovic S, Aschner M.

Toxicol Appl Pharmacol. 2011 Nov 1;256(3):219-26. doi: 10.1016/j.taap.2011.06.001. Epub 2011 Jun 13.

7.

Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.

Rhodes LV, Short SP, Neel NF, Salvo VA, Zhu Y, Elliott S, Wei Y, Yu D, Sun M, Muir SE, Fonseca JP, Bratton MR, Segar C, Tilghman SL, Sobolik-Delmaire T, Horton LW, Zaja-Milatovic S, Collins-Burow BM, Wadsworth S, Beckman BS, Wood CE, Fuqua SA, Nephew KP, Dent P, Worthylake RA, Curiel TJ, Hung MC, Richmond A, Burow ME.

Cancer Res. 2011 Jan 15;71(2):603-13. doi: 10.1158/0008-5472.CAN-10-3185. Epub 2010 Dec 1. Erratum in: Cancer Res. 2011 May 1;71(9):3432.

8.

Peaceful use of disastrous neurotoxicants.

Finkelstein Y, Milatovic D, Lazarovici P, Ophir A, Richter ED, Aschner M, Lecht S, Marcinkiewicz C, Lelkes PI, Zaja-Milatovic S, Gupta RC, Brodsky B, Rosengarten A, Proscura E, Shapira E, Wormser U.

Neurotoxicology. 2010 Sep;31(5):608-20. doi: 10.1016/j.neuro.2010.06.009. Epub 2010 Jul 8. Review.

PMID:
20620165
9.

Morphometric analysis in neurodegenerative disorders.

Milatovic D, Montine TJ, Zaja-Milatovic S, Madison JL, Bowman AB, Aschner M.

Curr Protoc Toxicol. 2010 Feb;Chapter 12:Unit 12.16. doi: 10.1002/0471140856.tx1216s43.

10.

The Foxc2 transcription factor regulates tumor angiogenesis.

Sano H, Leboeuf JP, Novitskiy SV, Seo S, Zaja-Milatovic S, Dikov MM, Kume T.

Biochem Biophys Res Commun. 2010 Feb 5;392(2):201-6. doi: 10.1016/j.bbrc.2010.01.015. Epub 2010 Jan 12.

11.

Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist.

Zaja-Milatovic S, Gupta RC, Aschner M, Milatovic D.

Toxicol Appl Pharmacol. 2009 Oct 15;240(2):124-31. doi: 10.1016/j.taap.2009.07.006. Epub 2009 Jul 14.

12.

Oxidative damage and neurodegeneration in manganese-induced neurotoxicity.

Milatovic D, Zaja-Milatovic S, Gupta RC, Yu Y, Aschner M.

Toxicol Appl Pharmacol. 2009 Oct 15;240(2):219-25. doi: 10.1016/j.taap.2009.07.004. Epub 2009 Jul 14.

13.

Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy.

Yang J, Zaja-Milatovic S, Thu YM, Lee F, Smykla R, Richmond A.

Mol Cancer Ther. 2009 Mar;8(3):636-47. doi: 10.1158/1535-7163.MCT-08-0749. Epub 2009 Mar 10.

14.

CXC chemokines and their receptors: a case for a significant biological role in cutaneous wound healing.

Zaja-Milatovic S, Richmond A.

Histol Histopathol. 2008 Nov;23(11):1399-407. doi: 10.14670/HH-23.1399. Review.

15.

Pharmacologic suppression of oxidative damage and dendritic degeneration following kainic acid-induced excitotoxicity in mouse cerebrum.

Zaja-Milatovic S, Gupta RC, Aschner M, Montine TJ, Milatovic D.

Neurotoxicology. 2008 Jul;29(4):621-7. doi: 10.1016/j.neuro.2008.04.009. Epub 2008 Apr 29.

16.

Short tail with skin lesion phenotype occurs in transgenic mice with keratin-14 promoter-directed expression of mutant CXCR2.

Yu Y, Su Y, Opalenik SR, Sobolik-Delmaire T, Neel NF, Zaja-Milatovic S, Short ST, Sai J, Richmond A.

J Leukoc Biol. 2008 Aug;84(2):406-19. doi: 10.1189/jlb.0807544. Epub 2008 May 27.

17.
18.

Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells.

Schutyser E, Su Y, Yu Y, Gouwy M, Zaja-Milatovic S, Van Damme J, Richmond A.

Eur Cytokine Netw. 2007 Jun;18(2):59-70. Epub 2007 Jun 26.

19.

Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity.

Maezawa I, Zaja-Milatovic S, Milatovic D, Stephen C, Sokal I, Maeda N, Montine TJ, Montine KS.

J Neuroinflammation. 2006 Aug 25;3:21.

20.

Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies.

Zaja-Milatovic S, Keene CD, Montine KS, Leverenz JB, Tsuang D, Montine TJ.

Neurology. 2006 May 23;66(10):1591-3.

PMID:
16717229
21.

Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease.

Zaja-Milatovic S, Milatovic D, Schantz AM, Zhang J, Montine KS, Samii A, Deutch AY, Montine TJ.

Neurology. 2005 Feb 8;64(3):545-7.

PMID:
15699393
22.

Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immune response in vivo.

Milatovic D, Zaja-Milatovic S, Montine KS, Shie FS, Montine TJ.

J Neuroinflammation. 2004 Oct 21;1(1):20.

23.

Supplemental Content

Loading ...
Support Center